The market is driven by the consumer awareness of health care resulting in access for treatment along with increase in the global ageing populace which faces these kind of health problems at that age.
View Full Report at: http://www.marketresearchreports.biz/analysis/505884
Table of Contents
1. Research Methodology
2. Product Overview
3. Executive Summary
4. Global Blood Plasma Market: An Analysis
4.1. Global Blood Plasma Market: Size, Growth and Forecast
4.1.1. By Value & Forecast
4.2. Global Blood Plasma Market: Segment Shares & Analysis
4.2.1. By Product Type
4.2.2. By Company
4.3. Global Albumin Type Blood Plasma Market: Size, Growth and Forecast
4.3.1. By Volume
4.3.2. By Value
4.3.3 By Company
4.4. Global IVIG Type Blood Plasma Market: Size, Growth and Forecast
4.4.1. By Value
4.4.2 By Volume
4.5. Global Factor VIII Type Blood Plasma Market: Size, Growth and Forecast
4.5.1 Overview
4.5.2 By Value
4.5.3 By Volume
4.6. Other Blood Products Market: Size, Growth and Forecast
4.6.1. By Value (Forecast 2020F)
5. North America Blood Plasma Market: Size, Growth and Forecast
5.1. Overview
5.2. By Value (Forecast 2015E-2020F)
5.3. Factors Affecting Market
Download Sample Copy of This Report at: http://www.marketresearchreports.biz/sample/sample/505884
6. APAC Blood Plasma Market: Size, Growth and Forecast
6.1. Overview
6.2. By Value (Forecast 2015E-2020F)
6.3. Factors Affecting Market
7. Europe Blood Plasma Market: Size, Growth and Forecast
7.1. By Value (Forecast 2015E-2020F)
8. RoW Blood Plasma Market: Size, Growth and Forecast
8.1. Overview
8.2. By Value (Forecast 2015E-2020F)
8.3. Factors Affecting Market
9. Blood Plasma Market Trends
9.1.Overview
9.1.1. Solid and Stable Pricing Power in IG Market
9.1.2. Fast Growth of SCIG Market
9.1.3. Industrial Fractionators Planning Capacity Expansion
9.1.4. Increase in Albumin Market in China
9.1.5. Immunoglobulin Segment- High Profitability and Strength
10. Global Blood Plasma Market Dynamics
10.1. Growth Drivers
10.1.1. Augmentation in Plasma accumulations in the US
10.1.2. Rise in Global Healthcare Expenditure
10.1.3. Growth in Ageing Population
10.1.4. Growth in Male Population
10.1.5. Development Potential from New Indications
10.2. Challenges
10.2.1. Rivalry from Recombinant Factor VIII
10.2.2. Prospective Threat to Immunoglobulin Market
10.2.3. Costing Pressure in Tenders in Plasma-Derived FVIII Market
10.2.4. High Manufacturing and Safety Cost
11. Blood Plasma Market: Policy and Regulatory Landscape
11.1. WHO Blood Safety Regulations
11.2. FDA Blood Safety Regulations
11.3. CANADA CAN/CSA-Z902-10 (R2015) - Blood and blood components
11.4. PHARMACEUTICAL AND FOOD SAFETY BUREAU (PFSB) JAPAN
11.5. UK Blood Safety Regulations
11.6. Australia Blood Safety Regulations
11.7. India Plasma Product Safety Regulations
